Crowson 2003
Crowson 2003
Systemic vasculitides constitute a significant diagnostic ferative disease. Identification of the type and calibre
challenge in the inpatient and ambulatory care set- of vessels involved and the pattern of inflammation is
tings. Accurate diagnosis requires a careful integration integral to isolating the etiology.5 A vasculitis confined
of clinical findings with the results of serologic, patho- to capillaries and post capillary venules of the super-
logic and diagnostic imaging studies. The skin is com- ficial plexus is typical for LCV related to ingestion or
monly involved in vasculitic disorders reflecting exposure to drugs, chemicals, foodstuffs and low-
systemic disease states as well as inthe context of hyper- grade infection.6 Neutrophilic and/or lymphocytic
sensitivity disorders in which disease expression is lar- infiltrates with mural necrosis and thrombosis of capil-
gely confined to the skin. The skin therefore offers a laries and venules throughout the sampled dermis is
window to diagnosis and affords a ready source of prototypically seen in cases of acute and chronic septic
accessible tissue for biopsy. With respect to disease vasculitis, systemic vasculitic syndromes and con-
mechanisms, the skin manifests a spectrum of vasculi- nective tissue disease (CTD).Vasculitis confined to the
tides that reflect injury by circulating immune com- subcutaneous fat may be observed in benign cutaneous
plexes, antiendothelial cell antibodies, and cell polyarteritis nodosa (PAN) and in superficial migra-
mediated immunity (CMI). Arthus type III reactions tory thrombophlebitis, the latter a manifestation of
occur when antigencomplexedto IgG or IgM activates certain systemic diseases such as BD, Buerger's disease,
the direct complement cascade sequence; a leuko- underlying malignancy and lupus anticoagulant. The
cytoclastic vasculitis (LCV) is the hallmark.1^4 The vasculitides are broadly classified inTable1.7
type II immune mechanism is operative when anti-
bodies directed against endothelial antigenic targets
such as in patients with systemic lupus erythematosus Leukocytoclastic vasculitis
(SLE), rheumatoid arthritis (RA), dermatomyositis, The classification of LCV involving small vessels in the
scleroderma and Behcet's disease (BD) generate what skin is broad. It encompasses serum sickness,6 chronic
is typically a pauci-inflammatory thrombogenic vas- vascultic syndromes such as granuloma faciale and
culopathy and/or a lymphocytic vasculitis. A type IV erythema elevatum diutinum,8^13 IgA-associated
(CMI) immune reaction may be the operative vasculitis including Henoch Schonlein purpura
mechanism underlying a granulomatous vasculitis in (HSP) (Fig.1),14^22 abnormal serum proteins including
the setting of Crohn's disease, sarcoidosis, postherpetic cryoglobulinemia and hypergammaglobulinemia
zosteriform eruptions, tuberculosis and lymphoproli- of Waldenstrom,23^28 hereditary deficiencies of
161
Crowson et al.
Table 1. Modified Lie classification of vasculitis (after Bonsib, 2001)7
A.Infectious angiitis
Spirochetal
Mycobacterial
Pyogenic bacteria
Rickettsial
Viral
Whipple
B.Noninfectious angiitis
Involving large, medium-sized, and small vessels
Takayasu's arteritis
Granulomatous (giant cell),Cranial (temporal) and
Extracranial giant cell arteritis
Arteritis of rheumatic diseases and spondyloarthropathies
Involving medium-sized and small vessels
Thromboangitis obliterans
Polyarteritis (periarteritis)
Polyarteritis nodosa
Microscopic polyarteritis
Infantile polyarteritis
Kawasaki's arteritis
Pathergic-allergic granulomatosis and angiitis
Wegener's granulomatosis
Churg ^ Strauss syndrome
Necrotizing sacroid granulomatosis
Vasculitis of collagen vascular disease
Rheumatoid arthritis
Seronegative arthropathies
Systemic lupus erythematosis
Dermatomyositis/polymyositis
Relapsing polychondritis
Systemic sclerosis Fig. 1. L e u ko c y to c l a st ic va s c u l it i de s : pa lp able pu r p u r a .
Sjogren's syndrome Leukocytoclastic vasculitides (LCVs) prototypically produce a pattern
Behcet's syndrome of palpable purpura affecting dependent parts, as exemplified in this case
Cogan's syndrome of Henoch-Schonlein purpura. Such a pattern will be manifested in
Rheumatic fever systemic vasculitic processes as well as in those cases of LCV reflecting
Involving small vessels localized cutaneous hypersensitivity states such as in the setting of drug-
Serum sickness induced LCV.
Henoch-Schonlein purpura
Drug-induced
Malignancy-associated related to hepatitis C (19%) or B (5%) infection,34
Retroperitoneal fibrosis while 10% reflected underlying malignancy, and
Lymphocytic vasculitis 9% an underlying CTD.34
Mixed cryoglobulinemia
Hypocomplementemia
Inflammatory bowel disease
Primary biliary cirrhosis Drug-induced leukocytoclastic vasculitis
Goodpasture's syndrome Drug-based etiology is implicated in approximately
Transplant vasculitis
10^24% of cases of LCV. 34,35 The most frequently
implicated agents are propylthiouracil, dilantin, quin-
complement,29^31 IgAdeficiency, 32 drug, chemical and idine, sulfonamides, penicillins, and allopurinol.34,35
foodstuff ingestion,33^35 systemic diseases such as In addition, roughly six per cent of patients with
PAN,36^40 RA,13,41^50 mixed connective tissue chronic cyclic neutropenia receiving granulocyte col-
disease,51 systemic LE,30,52^54 Sjogren's syndrome ony stimulating factor develop vasculitis within one
(SS), relapsing polychondritis,55 BD,56,57 Wegener's week of recovery of their absolute neutrophil count.33
granulomatosis (WG),58^61 allergic granulomatosis of Although some cases of drug-induced LCV manifest a
ChurgandStrauss(AGCS),4,62 inflammatoryboweldis- severe pan-dermal and/or pustular vasculitis, such as
ease (IBD),34 and infection. With respect to the LCVs those associated with calcium channel blockers and
of infection-based etiology, one must consider those to carbamazepine, the typical drug-induced LCV is
include id reactions to non-viable microbial antigens in mild in character and is confined to the superficial
the context of streptococcus, staphylococcus, hepatitis vascular plexus.
B and C, influenza, cytomegalovirus, parvovirus B19
and Mycobacterium sp. infection,20,34,65^78 as well as
septic vasculitides resulting from hematogenous dis- Urticarial vasculitis and serum sickness
semination of viable microbes. In one study from Urticarial vasculitis manifests recurrent episodes of
Spain, where the incidence of hepatitis C seroposi- raised edematous weals with blanchable erythema,
tivity is 0.8%, some 24% of cases of LCV were which typically last from 24 to 72 h and are associated
162
Cutaneous vasculitis
with pigmented residua and episodic arthritis.30,79
This condition results from complement activation
and may reflect a variety of underlying CTDs, most
commonly LE and SS, C1q esterase inhibitor defi-
ciency, underlying malignancy, and circulating
immune complexes containing an antigen that may be
exogenous, such as a drug, or endogenous, such as a
cryoprecipitate.30 The identification of an exogenous
antigen does not exclude the possibility that a given
patient may have a predisposing CTD diathesis. The
syndrome of serum sickness comprises fever, lympha-
denopathy, arthralgia, peripheral neuropathy, cuta-
neous vasculitis, and renal disease, and typically
occurs within10 days of administration of heterologous
serum in vaccines or antithymocyte globulin, intra-
venous and intracoronary streptokinase, drugs such as Fig. 2. Granuloma faciale: acute lesion. Perivascular nodules
predominated by neutrophils are seen in the mid dermis; there is a grenz
penicillin, sulfapyridine, sulfonamides, streptomycin, zone of papillary dermal sparing.
thiouracil and hydantoin and, exceptionally, insults
such as mosquito bites.80 Patients may experience pain
at the injection site 3 days before onset of the fully
expressed syndrome. Urticarial vasculitis and serum arthralgia respond dramatically to dapsone and sul-
sickness both prototypically manifest an interstitial phonamides.9,10,12 Early lesions manifest angiocentric
and perivascular neutrophilic infiltrate accompanied neutrophilic infiltrates with leukocytoclasia and only
by slight leukocytoclasia and mild injurious vascular minimal fibrin deposition in the vessels of the upper
alterations, although when large amounts of serum are and mid dermis. Characteristic is a prominent extra-
used vasculitis may be intense. vascular infiltrate of neutrophils and lymphocytes
with a minor population of eosinophils, plasma cells,
or lipid-laden histiocytes, thus the alternate designa-
tion of extracellular cholesterolosis. Older lesions mani-
Chronic cutaneous LCV syndromes fest as a nodular angiocentric eosinophilic fibrous
homogenization of the dermis associated with capil-
Granuloma faciale lary proliferation. One putative antigen source in
Granuloma faciale is a localized craniofacial LCV that EED may derive from bacteria of Streptococcus sp., as is
presents as recurrent brown-red plaques on the fore- suggested by the striking immunoreactivity seen after
head, cheeks, and ears.8 Similar lesions of the intradermal skin testing with streptokinase and strepto-
upper aerodigestive tract are termed eosinophilic dornase. Lesions of EED are also associated with
angiocentric fibrosis.81 Angiocentric mixed nodular underlying IgA myeloma, myelodysplasia and acute
inflammatory infiltrates with leukocytoclasia and myelogenous leukemia11 IBD, relapsing polychon-
mural fibrin deposition involve the mid dermis and dritis, and RA. Other syndromes that combine a LCV
spare the deep, papillary and adventitial dermis and with prominent extravascular neutrophilia include
subcutis (Fig. 2). Mononuclear cells and plasma cells WG, septic vasculitis, IBD, BD, and RA.41,45,56 The
may predominate, imparting a pseudolymphomatous dermal fibrogenesis is postulated to reflect activation
appearance to the more florid examples. Laminated of factor XIIIa-expressing dermal dendrocytes.82
angiocentric fibrosis with diminution in the intensity
of the inflammation typically ensues with advanced
lesional age. In the nasal cavity, this process results in Systemic neutrophilic vasculitic syndromes with
a nodular onion-skin pattern of hyalinization, which cutaneous LCV
produces a distinctive morphology. The principal systemic vasculitic syndromes are
PAN, Kawasaki's disease, mixed cryoglobulinemia, LE,
RA, BD,WG, and AGCS.4,59,60,62,83 All of these systemic
Erythema elevatum diutinum vasculitic syndromes can demonstrate a necrotizing
The symmetrical localization of disease in erythema cutaneous LCV and in some cases cutaneous involve-
elevatum diutinum (EED) is typically to the extensor ment may be their initial manifestation.
surfaces of joints and occasionally the buttocks, and
manifests as papules which progress to larger annular Systemic polyarteritis nodosa (seeTable 2)
lesions. The older lesion is an elevated red, purple, or The two major forms of systemic systemic polyarteritis
brown plaque. The cutaneous manifestations and the nodosa (PAN) are macroscopic PAN (MaPAN) and
163
Crowson et al.
Table 2. Clinical differences between polyarteritis nodosa and microscopic
polyangitis
Clinical feature Polyarteritis nodosa Microscopic polyangitis
Microaneurysms by angiography Yes No
Rapidly progressive nephritis No Yes
Pulmonary hemorrhage No Yes
Renovascular hypertension Yes (10^33%) No
Peripheralneuropathy Yes (50^80%) Yes (10^20%)
Positive hepatitis B serology Uncommon No
Positive ANCA serology Rare Frequent
Relapses Rare Frequent
164
Cutaneous vasculitis
regress correlates with longer duration of the acute
febrile phase and an age at onset of more than 2 years.
There is a subacute form that exhibits myocarditis,
arthritis and thrombocytosis. A minority of patients
manifest an arteritis that involves the skin. 86 The
histopathology of the skin rash is not well defined but
includes a psoriasiform dermatitis and an erythema
multiforme-like interface injury pattern. Homology
between microbial antigens and endogenous heat-
shock proteins has been suggested as the possible
pathogenetic basis, whereby possible infective triggers
include viruses such as Epstein^Barr virus and bac-
teria including pseudomonas, streptococcus, staphylo-
coccus, and rickettsia.
165
Crowson et al.
cryoglobulinemia causes a pauci-inflammatory
thrombogenic vasculopathy leading to tissue infarc-
tion. A necrotizing systemic PAN-like vasculitis char-
acterizes the type II and type III cryoglobulinemias.
Skin biopsies show a severe pandermal LCVextending
to subcutaneous arteries and veins. In addition to
intraluminal and mural fibrin deposition, eosinophilic
globular precipitates are seen in the lumina of the
inflamed vessels. Mononuclear cells predominate in
chronic lesions and some cases exhibit granulomatous
vasculitis. Precipitates of cryoglobulin are easy to dis-
tinguish from fibrin by their intense staining reaction
with periodic acid-Schiff.
166
Cutaneous vasculitis
respect to the presence or absence of antecedant infec- Systemic vasculitic syndromes with hybrid patterns
tion, extravascular neutrophilia as characterized by of vascular injury
epidermal pustulation or DH-like microabscesses is Certain CTD and systemic vasculitic syndromes may
seen in most infectious cases, and almost invariably manifest cutaneous lesions having two or more vascu-
the patient has other symptoms of HSP.20 lar reaction patterns. In patients with LE, RA, SS,
relapsing polychondritis, WG, and AGCS, pauci-
Bowel bypass syndrome/bowel arthritis dermatosis syndrome inflammatory thrombogenic vasculopathy, lympho-
An intermittent cutaneous eruption occasionally fol- cytic thrombogenic vasculopathy and vasculitis, LCV,
lows intestinal bypass surgery for morbid obesity or granulomatous vascultis, and pustular vasculitis may
extensive small bowel resection and comprises pur- be seen in concert or in isolation.
puric macules and papules on trunk and extremities
that evolve into necrotizing vesiculo-pustular lesions, Lupus erythematosus
sometimes accompanied by polyarthritis, malaise, and Clinical manifestations of LE range from a skin rash
fever. Originally termed bowel bypass syndrome, it with arthralgia to progressive multisystem organ fail-
is similar to that seen in patients with diverticulosis, ure and death. The diagnosis of SLE is based on the
peptic ulcer disease, and IBD, thus the more fulfillment of four of 11 criteria established by the
appropriate designation bowel arthritis dermatosis American College of Rheumatologists.97 In particular,
syndrome.90,91,94 An LCV may be present, but a one arrives at a diagnosis through the association of
Sweet's-like vascular reaction is prototypic. Skin serological abnormalities with clinical features includ-
biopsies also show papillary dermal edema, which ing a skin rash, arthralgia, arthritis, fever, Raynaud's
may lead to subepidermal vesiculation, epidermal pus- phenomenon, anemia, leukopenia, serositis, nephritis
tulation with variable necrosis and marked superficial and central nervous system disease.98,99 The vascular
dermal neutrophilic infiltrates. Most patients manifest lesions of SLE involve all calibers and types of vessels
demonstrable circulating immune complexes, includ- in all organ systems. The histologic patterns of blood
ing those containing cryoproteins. The principle anti- vessel injury encompass a pauci-inflammatory throm-
genic trigger may be peptidoglycans that derive from bogenic vasculopathy, lymphocytic vasculitis, and
intestinal bacteria, many of which are structurally and neutrophilic vascular reactions including LCV and a
antigenically similar to those of Streptococcus pyogenes. In systemic MaPAN-like vasculitis. A severe pandermal
addition to direct immunofluorescence testing, which vasculitis accompanied by thrombosis and resultant
has shown linear and granular deposits of immuno- infarction is the most common cutaneous manifesta-
globulins and complement along the dermoepidermal tion. The mechanism of vascular injury often reflects
junction (DEJ) and in vessels, one study demonstrated circulating immune complexes comprising immuno-
Escherichia coli antigens in a granular array along the globulin complexed to endogenous antigens such as
DEJ.96 cryoglobulins and nuclear components, while the
mechanisms of thrombosis include antibodies directed
Septic vasculitis at endothelial antigenic targets,100^103 deposition on
Skin biopsies from patients with acute septic vasculitis endothelium of circulating immune complexes that
demonstrate a severe pandermal LCV with neutro- result in endothelial cell injury with activation of the
phil- and bacteria-containing thrombi, extravascular clotting pathway, and other procoagulant factors such
neutrophilia including DH-like microabscesses and as lupus anticoagulant. In SLE, acute endothelial cell
neutrophilic exocytosis, and papillary dermal edema. injury has also been implicated in the evolution of a
The implicated microbial pathogens include meningo- symptom complex mimicking thrombotic thrombo-
coccus,staphylococcus,GroupAstreptococcus,pneumo- cytopenic purpura. The phenomenon of deep blood
coccus, pseudomonas, Vibria vulnificus, rickettsia vessel injury in LE and in other syndromes associated
except C. burnetti and candida.71 Vascular injury results with pro-coagulant states can effect deep vascular
from embolization of organisms, whereby bacterial occlusion, particularly in the lower extremities. The
endotoxins provoke complement activation and tumor result is a livedoid pattern (Fig. 8).
necrosis factor production rendering the endothelium
procoagulant and generating release of tissue factor
which promotesthrombosis. In chronic septic vasculitis Rheumatoid arthritis
the luminal thrombi are paucicellular and it is difficult Rheumatoid arthritis is a chronic inflammatory dis-
to demonstrate organisms within vessels despite the order that results in destruction of joints, articular
presence of immune complexes comprising bacterial cartilage and adjacent structures, with extra-articular
antigenic components and antibody. The prototypic manifestations including subcutaneous and dermal
organisms associated with chronic septic vasculitis are rheumatoid nodules and papules, episcleritis, inter-
meningococcus and gonococcus.68^72 stitial lymphocytic pneumonitis, hypersplenism
167
Crowson et al.
168
Cutaneous vasculitis
large vein and artery disease. The ocular manifesta- MiPAN. The combination of vasculitis and folliculitis
tions include uveitis, hypopyon iritis, optic neuritis is seen in pyoderma gangrenosum, mixed cryoglobuli-
and choroiditis. The intestinal manifestations of nemia, BD, IBD, RA (personal observation) and
entero-BD include diarrhea, constipation, abdominal pyodermatous eosinophilic folliculitis.92,105 Vascular
pain, vomiting, and melena, while neuro-BD com- thrombosis attributable to antibody mediated
prises brain stem dysfunction, meningoencephalitis, endothelial injury, protein C or S deficiency, factor
organic psychiatric symptoms, and mononeuritis mul- XII deficiency, inhibition of plasminogen activator,
tiplex. Renal disease is expressed as asymptomatic and circulating lupus anticoagulant has been
microhematuria and/or proteinuria, while an oligo- described.
arthritis may involve the wrist, elbow, knee, or ankle
joints.56 The skin lesions include erythema nodosum- Wegener's granulomatosis
like nodules, vesicles, pustules, pyoderma gangreno-
sum, Sweet's syndrome, a pustular pathergic tissue Cutaneous lesions of Wegener's granulomatosis include
reaction to needle trauma, superficial migratory subcutaneous nodules, ulcerating lesions producing a
thrombophlebitis, ulceration, infiltrative erythema, `malignant pyoderma' mainly in the head and neck,
acral purpuric papulonodular lesions, and acneiform hemorrhagic bullae, pustules, papules, ulcers, vesicles,
folliculitis.7,56 petechiae, and palpable purpura. LimitedWG encom-
The histopathology of the skin lesions has three main passes pulmonary disease with or without skin or gut
expressions: vascular, extravascular with or without lesions in the absence of upper respiratory tract and
vasculopathy, and acneiform. The cutaneous vasculo- kidney involvement. Superficial limited WG confined
pathy comprises a lymphocytic or granulomatous vas- to the skin or oral mucosa has been described. The
culitis with or without thrombosis, necrosis, or mural cutaneous manifestations of WG encompass collagen
fibrin deposition, a paucicellular thrombogenic vascu- degeneration, extravascular inflammation, and vascu-
lopathy, and a neutrophilic vascular reaction that litis. In cases of WG limited to the skin, upper respira-
involves capillaries as well as arteries and veins of all tory tract, mediastinum and/or retropertitoneum,
calibers. Neutrophilic vasculopathies include an LCV extravascular inflammation without vasculitis may
and a Sweet's-like reaction. With or without blood be seen. The extravascular inflammation includes
vessel injury, one may see extravascular mononuclear suppurative or suppurative and granulomatous inflam-
cell- or neutrophil-predominant inflammation of the mation with pseudoepitheliomatous hyperplasia and
dermis and/or panniculus. A histiocytic panniculitis intraepithelial microabscess formation; palisading
may be seen, while suppurative or mixed suppurative granulomata of Churg Strauss, GA or NL subtypes;
and granulomatous folliculitis characterizes the acnei- and foreign body giant cells with or without extravas-
form lesions.56 Acral purpuric papulonodular lesions cular neutrophilia.The vasculitic lesions involve capil-
show a lymphocytic interface dermatitis with lympho- laries, venules, arterioles, small arteries and veins
cytic exocytosis, dyskeratosis and a perivascular which show necrosis with an angiocentric infiltrate
lymphocytic infiltrate that recapitulates the mucosal ranging from a granulomatous to a neutrophil-
histology;57 the extracutaneous pathology tends to predominant pattern. Any of neutrophilic capillaritis,
mirror that found in the skin. For example, while the LCVor a PAN-like vasculitis may be seen, usually in
centers of oral aphthae manifest a dense neutrophilic concert with extravascular inflammation and collagen
infiltrate with necrosis of the epithelium and con- degeneration. Patients presenting with cutaneous
nective tissue pathergy of the submucosa, the peripheries LCV often have widespread disease whereas those
show dense lymphocytic infiltration of the submucosa, presenting with granulomatous inflammation without
lymphocytic exocytosis and epithelial degeneration; LCV less often have pulmonary and renal manifesta-
genital aphthae have the same appearance. The large tions. Some patients with cutaneous LCV may have a
vessel arteriopathy is an ischemic sequel of a mono- protacted superficial form of WG of skin and upper
nuclear cell vasculitis of the vasa vasorum, while venous respiratory tract, developing lung or kidney involve-
thrombosis may partly reflect hypercoagulability. The ment years later.59,60
renal manifestations include IgA nephropathy, focal
and diffuse proliferative glomerulonephritis, and amy- Allergic granulomatosis of Churg and Strauss
loidosis. The lymphocytic vasculitis recapitulates that Allergic granulomatosis of Churg-Strauss (AGCS) is a
seen with the CTDs, Degos'disease, and paraneoplas- systemic vasculitis in the setting of an atopic diathesis
tic vasculitis. A granulomatous vasculitis may also be comprising allergic rhinitis and/or asthma along with
observed in WG, AGCS, Crohn's disease, sarcoidosis, marked peripheral blood eosinophilia. In some
acquired hypogammaglobulinemia, a post-Herpetic patients vasculitis develops 30 years after the onset of
eruption, paraneoplastic syndromes, RA, hypersensi- asthma, the latter abating with the onset of vasculitis.
tivity to certain infections including syphilis and tuber- The vasculitis closely resembles WG or MiPAN and
culosis, scleroderma, and the late-stage lesions of mainly involves small arteries and veins with a few
169
Crowson et al.
Table 3. Frequency of anti-neutrophil cytoplasmic antibody (ANCA) with specificity
of proteinase 3 or myeloperoxidase in patients with active untreated microscopic
polyarteritis,Wegener's granulomatosis, and Churg ^ Strauss syndrome
Micro-
scopic Wegener's Churg-Strauss
polyangitis granulomatosis syndrome
PR3 ANCA 40% 75% 10%
MPO-ANCA 50% 20% 60%
Negative 10% 5% 30%
170
Cutaneous vasculitis
and diagnostic imaging studies. The pathologist must 21. Garcia-Porrua C, Gonzlez-Gay MA. Comparative clinical and
be cognizant of the limitations of morphology when epidemiological study of hypersensitivity vasculitis versus
Henoch-Schonlein purpura in adults. Semin Arthritis Rheum
attempting to support his or her clinicians, and must
1999; 28: 404.
also know what questions to ask in order to formulate 22. Rovel-Guitera P, Diemert MC, Charuel JL et al. IgA antineu-
a biopsy report that is contributory to patient care. trophilic cytoplasmic antibodies in cutaneous vasculitis. Br J
Dermatol 2000;143: 99.
23. McKenzie AW, Earle JHO, Lockey E et al. Essential cryo-
References globulinemia. BrJ Dermatol1982;7: 673.
1. Sams WM Jr, Thorne EG, Small P et al. Leukocytoclastic vas- 24. Levo Y, Gorevic PD, Kassab HJ et al. The association between
culitis. Arch Dermatol1976;112: 219. hepatitis B virus and essential mixed cryoglobulinemia. N Eng
2. McCoombs RP. Systemic `allergic' vasculitis. JAMA 1965; J Med 1977; 296: 1501.
194: 1059. 25. Gorevic PD, Kassab HJ, LevoYet al. Mixed cryoglobulinemia:
3. CallenJP, ChandraJJ,VoorheesJJ. Cutaneous angiitis (vasculi- clinical aspects and long-term follow-up of 40 patients. Am
tis). IntJ Dermatol1978;17: 105. J Med 1980; 69: 287.
4. Mackel SE, Jordon RE. Leukocytoclastic vasculitis. A cuta- 26. Boom BW, Brand A, Bavinck JN et al. Severe leukocytoclastic
neous expression of immune complex disease. Arch Dermatol vasculitis of the skin in a patient with essential mixed cryo-
1982;118: 296. globulinemia treated with high-dose gamma-globulin intra-
5. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of sys- venously. Arch Dermatol1988;124: 1550.
temic vasculitides. Proposal of an international consensus con- 27. Szymanski IO, Pullman JM, Underwood JM. Electron micro-
ference. Arthritis Rheum 1994; 37: 187. scopic and immunochemical studies in a patient with hepatitis
6. Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous C virus infection and mixed cryoglobulinemia type II. Am
small-vessel vasculitis. J Am Acad Dermatol1998; 39: 667. JClin Pathol1994;102: 278.
7. Bonsib S. Polyarteritis nodosa. Semin Diagn Pathol 2001;18: 14. 28. Dammacco F. Localization of hepatitis C virus antigens in liver
8. Pedace FJ, Perry HO. Granuloma faciale. A clinical and histo- and skin tissues of chronic hepatitis C virus-infected patients
pathologic review. Arch Dermatol1966; 94: 387. with mixed cryoglobulinemia. Hepatology 1995; 21: 305.
9. Mrez JP, Newcomber VD. Erythema elevatum diutinum. Arch 29. Lhotta K, Kronenberg F, Joannidis M, Feichtinger H, Konig P.
Dermatol1967; 96: 235. Wegener's granulomatosis and Henoch-Schonlein purpura in a
10. Katz SI, Gallin JI, Hertz KC et al. Erythema elevatum diuti- family with hereditary C4 deficiency. Adv Exp Med Biol 1993;
num: skin and systemic manifestations, immunologic studies, 336: 415.
and successful treatment with dapsone. Medicine (Baltimore) 30. Stone NM, Williams A, Wilkinson JD, Bird G. Systemic lupus
1977; 56: 443. erythematosus with C1q deficiency. Br J Dermatol 2000; 142:
11. Aractingi S, Bachmeyer C et al. Simultaneous occurrence of two 521.
rare cutaneous markers of poor prognosis in myelodysplastic 31. Sessler R, Hasche G, Olbricht CJ. Hypocomplementemic urti-
syndrome: erythema elevatum diutinum and specific lesions. Br carial vasculitis syndrome. Dtsch Med Wochenschr 2000; 125:
J Dermatol1994;131: 112. 1003.
12. Gibson LE, el-Azhary RA. Erythema elevatum diutinum. Clin 32. Liu MF, Li JS, Tsao CJ et al. Selective IgA deficiency with
Dermatol 2000;18: 295. recurrent vasculitis of the central nervous system. Clin Exp
13. Nakajima H, Ikeda M,YamamotoY, Kodama H. Erythema ele- Rheumatol1998;16: 77.
vatum diutinum complicated by rheumatoid arthritis. J Derma- 33. Jain KK. Cutaneous vasculitis associated with granulocyte
tol1999; 26: 452. colony-stimulating factor. J Am Acad Dermatol 1994; 31
14. Allen DM, Diamond LK, Howell DA. Anaphylactoid puru- (2 Part 1): 213.
pura in children (Schonlein^ Henoch syndrome). Am J Dis 34. Sais G, Vidaller A et al. Prognostic factors in leukocytoclastic
Child1960; 99: 833. vasculitis. A clinicopathologic study of 160 patients. Arch Der-
15. Stevenson JA, Leong LA, Cohen AH et al. Henoch-Schonlein matol1998;134: 309.
purpura. Simultaneous demonstration of IgA deposits in 35. Garcia-Porrua C, Gonzlez-Gay MA, Lopez-Lazaro L. Drug
involved skin, intestine, and kidney. Arch Pathol 1982;106: 192. associated cutaneous vasculitis in adults in northwestern Spain.
16. Mills JA, Michel BA, Bloch DA et al. The American College of J Rheumatol1999; 26: 1942.
Rheumatology 1990 criteria for the classification of Henoch- 36. Ketron LW, Bernstein JC. Cutaneous manifestations of peri-
Schonlein purpura. Arthritis Rheum 1990; 33: 1114. arteritis nodosa. Arch Dermatol Syph1939; 40: 929.
17. Michel BA, Hunder GG, Bloch DA, Calabrese LH. Hypersensi- 37. Borrie P. Cutaneous polyarteritis nodosa. Br J Dermatol 1972;
tivity vasculitis and Henoch-Schonlein purpura: a comparison 87: 87.
between the 2 disorders. J Rheumatol1992;19: 721. 38. Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis
18. Egan CA,TaylorTB, Meyer LJ, Petersen MJ, ZoneJJ. IgA1is the and response to treatment in polyarteritis. Mayo Clin Proc
major IgA subclass in cutaneous blood vessels in Henoch- 1980; 55: 146.
Schonlein purpura. BrJ Dermatol1999;141: 859. 39. Diaz-Perez JL, Winkelmann RK. Cutaneous polyarteritis
19. Egan CA, O'Reilly MA, Meadows KP, Zone JJ. Relapsing nodosa. Arch Dermatol1983;119: 326.
Henoch-Schonlein purpura associated with Pseudomonas aer- 40. Savage COS, Winearls CG, Evans DJ et al. Microscopic poly-
uginosa pyelonephritis. J Am Acad Dermatol 2000; 42 (2 Part arteritis: presentation, pathology, and prognosis. QJ Med 1985;
2): 381. 56: 467.
20. Magro CM, Crowson AN. The clinical and histological spec- 41. Spiera H, Plotz CM. Rheumatoid vasculitis: a report of seven
trum of IgA-associated vasculitis. Am J Dermatopathol 1999; patients treated with cyclophosphamide. Arthritis Rheum 1972;
21: 234. 14: 1271.
171
Crowson et al.
42. Scott DGI, Bacon PAA,Tribe CR. Systemic rheumatoid vascu- 65. Crowson AN, Magro CM, Dawood MR. A causal role for
litis. A clinical and laboratory study of 50 cases. Medicine 1981; parvovirus B19 infection in adult dermatomyositis and other con-
60: 288. nective tissue disease syndromes. JCutan Pathol 2000; 27: 505.
43. Gray RG, Popp MJ. Necrotizing vasculitis as the initial 66. Magro CM, Crowson AN, Dawood M, Nuovo GJ. Parvoviral
manifestation of rheumatoid arthritis. J Rheumatol 1983; 10: infection of endothelial cells in cutaneous lesions ^ possible role
326. in vasculitis and autoimmune diseases. J Rheumatol 2002; 29:
44. Magro CM, Crowson AN, Regauer S. Granuloma annulare 1227.
and necrobiosis lipoidica tissue reactions in association with 67. Watson DA. Pustular vasculitis complicating BCG vaccination.
systemic disease. Hum Pathol1996; 27: 50. Tuber Lung Dis 1992;73: 126.
45. Schneider HA,Yonker RA, Katz Pet al. Rheumatoid vasculitis: 68. Hill WR, Kinney TD. The cutaneous lesions in acute menin-
experience with 13 patients and review of the literature. Semin gococcemia. JAMA1947;134: 513.
Arthritis Rheum 1985;14: 280. 69. Abu-Nassar H, Fred HL,Yow EM. Cutaneous manifestations of
46. Smith ML, JorizzoJL, Semble E. Rheumatoid papules: lesions gonococcemia. Arch Intern Med 1963;112: 731.
showing features of vaculitis and palisading granuloma. J Am 70. Neilsen LT. Chronic meningococcemia. Arch Intern Med1964;
Acad Dermatol1989; 20: 348. 114: 29.
47. Lowe L, Kornfeld B, Clayman J, Golitz LE. Rheumatoid neu- 71. Plaut ME. Staphylococcal septicemia and pustular purpura.
trophilic dermatitis. J Cutan Pathol 1992;19: 48. Arch Dermatol1969; 99: 82.
48. Higaki Y, Yamashita H, Sato K, Higaki M, Kawashima M. 72. Shapiro L,TeischJA, Brownstein MH. Dermatohistopathology
Rheumatoid papules: a report on four patients with histopatho- of chronic gonococcal sepsis. Arch Dermatol1973;107: 403.
logic analysis. J Am Acad Dermatol1993; 28: 406. 73. Sergent JS, Cockshin MD, Christian CL et al. Vasculitis with
49. Wolf P, GretlerJ, Aglas F, Auer-Grumbach P, Rainer F. Anticar- hepatitis B antigenemia: long-term observation in nine
diolipin antibodies in rheumatoid arthritis: their relation to patients. Medicine (Baltimore) 1976; 55: 1.
rheumatoid nodules and cutaneous vascular manifestations. 74. O'Brien TJ, Mcdonald MI, Reid BF, Trethewie D. Strepto-
BrJ Dermatol1994;131: 48. coccal septic vasculitis. AustralasianJ Dermatol1995; 36 (4): 211.
50. Ikeda E, Uchigasaki S, Baba S, Suzuki H. Multiple rheumatoid 75. Lotti T, Commacchi C, Ghersetich I. Cutaneous necrotizing
papules characteristic of the early stage of rheumatoid vasculi- vasculitis. IntJ Dermatol1996; 35: 457.
tis. EurJ Dermatol1999; 9: 313. 76. Garcia-Porrua C, Gonzlez-Gay MA. Bacterial infection pre-
51. Magro CM, Crowson AN, Regauer S.The dermatopathology of senting as cutaneous vasculitits in adults. Clin Exp Rheumatol
mixed connective tissue disease. Am J Dermatopathol 1997; 19: 1999;17: 471.
205. 77. Magro CM, Crowson AN, Peeling R. Vasculitis as the basis
52. Jarcho S. Lupus erythematosus associated with visceral vascu- of cutaneous lesions in Reiter's disease. Hum Pathol1995;26: 633.
lar lesions. Johns Hopkins Hosp Bull 1936; 59: 262. 78. Tan RS-H. Acute generalized pustular bacterid. An unusual
53. Estes D, Christian DL. The natural history of systemic lupus manifestation of leukocytoclastic vasculitis. BrJ Dermatol1974;
erythematosus by prospective analysis. Medicine1971; 50: 85. 91: 209.
54. Cardinale C, Caproni M, Bernacchi E, Amato L, Fabbri P.The 79. Mehregean DR, Hall MJ, Gibson LE. Urticarial vasculitis. a
spectrum of cutaneous manifestations in lupus erythematosus histopathologic and clinical review of 72 cases. J Am Acad Der-
^ the Italian experience. Lupus 2000; 9: 417. matol1992; 26: 441.
55. Moutsopoulos HM, Chused TM, Mann DL et al. Sjogren's 80. Gaig P, Garcia-Ortega P, et al.Serum sickness ^like syndrome
syndrome (sicca syndrome): current issues. Ann Intern Med due to mosquito bite. JInvest Allergol Clin Immunol1999;9:190.
1980; 92: 2112. 81. Altemani AM, Pilch BZ, Sakano E, AltemaniJM. Eosinophilic
56. Magro CM, Crowson AN. Cutaneous manifestations of Beh- angiocentric fibrosis of the nasal cavity. Mod Pathol 1997; 10:
cet's disease. IntJ Dermatol1995; 34: 159. 391.
57. King R, Crowson AN, Murray E, Magro CM. Acral purpuric 82. Pacheco LS, Sotto MN. Factor XIIIa dermal dendrocytes in
papulonodular lesions as a manifestation of Behcet's disease. Int erythema elevatum diutinum and ordinary cutaneous leuko-
J Dermatol1995; 34: 190. cytoclastic vasculitis lesions. JCutan Pathol 2000; 27: 136.
58. Fahey JL, Leonard E, Churg J et al. Wegener's granulomatosis. 83. Paronetto F, Deppisch DL,Tuchman LR. Lupus erythematosus
AmJ Med 1954;17: 168. with fatal hemorrhage into the liver and lesions resembling
59. Patten SF, Tomecki KJ. Wegener's granulomatosis: those of periarteritis nodes and malignant hypertension.
cutaneous and oral mucosal disease. J Am Acad Dermatol Immunocytohemical observations. AmJ Med 1964; 36: 148.
1993; 28: 710. 84. Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis
60. Barksdale SK, Hallahan CW et al. Cutaneous pathology in (Microscopic polyarteritis) Semin Diagn Pathol 2001;18: 3.
Wegener's granulomatosis. A clinicopathologic study of 75 85. Kawasaki T. Acute febrile mucocutaneous syndrome with
biopsies in 46 patients. AmJ Surg Pathol1995;19: 161. lymph node involvement with specific desquamation of the fin-
61. Shimizu E, Nakabayashi I, Kubota T et al. A case report of gers and toes in children. Arerugi 1967;16: 178.
mixed P- and C-ANCA positive patients with pauci-immune 86. Elamin A. Kawasaki disease in a Sudanese family. Ann Trop
crescentic glomerulonephritis. Clin Nephrol1995; 44: 266. Paediatrics 1993;13 (3): 263.
62. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis 87. Pileri P, Uematsu U, Campagnoli S et al. Binding of hepatitis C
and periarteritis nodosa. AmJ Pathol 1951; 27: 277. virus to CD81. Science 1998; 282: 938.
63. Dicken CH, Winkelman RK. The Churg-Strauss granuloma: 88. Sasso EH. The rheumatoid factor response in the etiology of
cutaneous, necrotizing, palisading granuloma in vasculitis syn- mixed cryoglobulins associated with hepatitis C virus infection.
dromes. Arch Pathol Lab Med 1978;102: 576. Ann Interne Med (Paris) 2000;151: 30.
64. Crotty CP, Deremee RA,Winkelmann RK. Cutaneous clinico- 89. Hausfater P, Rosenthal E, Cacoub P. Lymphoproliferative
pathogic correlation of allergic granulomatosis. J Am Acad disease and hepatitis C infection. Ann Interne Med (Paris)
Dermatol1981; 5: 571. 2000;151: 53.
172
Cutaneous vasculitis
90. Ely PH. The bowel bypass syndrome: a response to bacterial marker for nephritis and vasculitis. Clin Exp Immunol 1991;
peptidoglycans. J Am Acad Dermatol1980; 2: 473. 85: 254.
91. Jorizzo JL, Apisarnthanarax P, Subrt P et al. Bowel bypass 102. Magro CM, Crowson AN. The cutaneous pathology asso-
syndrome without bowel bypass. Bowel associated dermato- ciated with seropositivity for antibodies to Ro/SSA. A clinico-
sis ^arthritis syndrome. Arch Intern Med 1983;143: 457. pathological study of 23 adult patients without subacute
92. Magro CM, Crowson AN. Sterile neutrophilic folliculitis with cutaneous lupus erythematosus. Am J Dermatopathol 1999;
perifollicular vasculopathy: a distinctive cutaneous reaction 21: 129.
pattern reflecting systemic disease. J Cutan Pathol 1998; 103. Accinni L, Dixon FJ. Degenerative vascular disease and
25: 215. myocardial infarction in mice with lupus^ like syndrome.
93. Magro CM, Crowson AN.The cutaneous neutrophilic vascular AmJ Pathol 1979; 96: 477.
injury syndromes: a review. Semin Diagn Pathol 2001;18: 47. 104. Jorizzo JL, Olansky AJ, Stanley RJ. Superficial ulcerating
94. McNeely MC, Jorizzo JL, Solomon AR et al. Primary idio- necrobiosis in rheumatoid arthrititis. A variant of the necro-
pathic cutaneous pustular vasculitis. J Am Acad Dermatol biosis lipoidica-rheumatoid nodule spectrum? Arch Dermatol
1986;14: 939. 1982;118: 255.
95. Magro CM, Crowson AN. The dermatopathological mani- 105. Magro CM, Crowson AN. Necrotizing eosinophilic folliculitis
festations of rheumatoid arthritis. a clinical and histopatholo- as a manifestation of the atopic diathesis. IntJ Dermatol 2000;
gical study of 44 cases. JCutan Pathol, in press. 39: 672.
96. Utsinger PD. Systemic immune complex disease following 106. Burrows NP, Lockwood CM. Antineutrophil cytoplasmic
intestinal bypass surgery: bypass disease. J Am Acad Derma- antibodies and their relevance to the dermatologist. Br J Der-
tol1980; 2: 488. matol1995;132: 173.
97. Tan EM, Cohen AS, FriesJFet al.The 1982 revised criteria for 107. Falk RJ, Nachman PH, Hogan SL, JennetteJC. ANCA glomer-
the classification of systemic lupus erythematosus. Arthritis ulonephritis and vasculitis: a Chapel-Hill perspective. Proc
Rheum 1982; 25: 1271. Natl Acad Sci USA1990; 87: 4115.
98. Magro CM, Crowson AN, Harrist TJ. The use of antibody to 108. Terjung B, Spengler U, Sauerbruch T, Worman HJ. Atypical
C5b-9 in the subclassification of lupus erythematosus. BrJ Der- p-ANCA in IBD and autoimmune liver disorders reacts with
matol1996;134: 855. a myeloid-specific 50 kD nuclear envelope protein (Abstract).
99. Crowson AN. Superficial and deep perivascular dermatitis. Clin Exp Immunol 2000;120 (Suppl.1): 53.
In: Barnhill R, Crowson AN, Busam K, Granter S Ed's. Text- 109. Frenzer A, Fierz W, Rundler E, Hammer B, Binek J. Atypical,
book of Dermatopathology. New York: McGraw-Hill Co., cytoplasmic and perinuclear anti-neutrophil cytoplasmic
1998: 69. antibodies in patients with inflammatory bowel disease.
100. Shingu M, Hurd ER. Sera from patients with systemic lupus J Gastroenterol Hepatol1998;13: 950.
erythematosus reactive with human endothelial cells. J Rheu- 110. Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjogren's
matol1981; 8: 581. syndrome. Association of Anti-Ro (SS-A) antibodies with vas-
101. D'Cruz DP, Houssiau FA, Ramirez G et al. Antibodies to culitis, hematologic abnormalities and serologic hyperreactiv-
endothelial cells in systemic lupus erythematosus: a potential ity. Ann Int Med 1983; 98: 155.
173